Types of Strategic Alliances and Firms’ Performance: Empirical Evidence from the Taiwanese Public-Listed Companies in Biotechnological Industries
Date Issued
2004
Date
2004
Author(s)
Huang, Chi-Jui
DOI
zh-TW
Abstract
This study aims at combining theory and research on strategic alliance, especially those which can be observed in biotechnological sector, to investigate the impact of variation in types of strategic alliances on firms’ performance.
By applying correlations analysis, variance analysis and multiple linear regression analysis, 487 alliances of thirty-seven Taiwan’s public-listed biotechnological companies’ are analyzed.
The empirical analysis provided broad support for the paper’s hypothesis. The main findings of this study are summarized as follows:
1.Firm size and age affect firm performance positively.
2.Biotechnological companies can enhance their performance by establishing alliances.
3.Biotechnological companies can enhance their performance by entering into more foreign alliances and raising foreign alliances ratio.
4.Biotechnological companies furthermore enhance their performance by forming more equity alliances and raising equity alliances ratio.
5.Biotechnological companies can enhance their financial performance by forming more marketing and multi-type alliances. Biotechnological companies can also enhance their R&D performance by forming more R&D alliances.
6.This study also finds that alliance diversity dose not affect biotechnological companies performance at their present stage of product life cycles.
Finally, the study presents some suggestions to our government, as well as to biotechnological companies and future research.
By applying correlations analysis, variance analysis and multiple linear regression analysis, 487 alliances of thirty-seven Taiwan’s public-listed biotechnological companies’ are analyzed.
The empirical analysis provided broad support for the paper’s hypothesis. The main findings of this study are summarized as follows:
1.Firm size and age affect firm performance positively.
2.Biotechnological companies can enhance their performance by establishing alliances.
3.Biotechnological companies can enhance their performance by entering into more foreign alliances and raising foreign alliances ratio.
4.Biotechnological companies furthermore enhance their performance by forming more equity alliances and raising equity alliances ratio.
5.Biotechnological companies can enhance their financial performance by forming more marketing and multi-type alliances. Biotechnological companies can also enhance their R&D performance by forming more R&D alliances.
6.This study also finds that alliance diversity dose not affect biotechnological companies performance at their present stage of product life cycles.
Finally, the study presents some suggestions to our government, as well as to biotechnological companies and future research.
Subjects
策略聯盟
聯盟績效
生技產業
聯盟類型
Alliance Performance
Biotechnological Industries
Social Network
Strategic Alliance
Types of Strategic Alliance
Type
thesis
File(s)![Thumbnail Image]()
Loading...
Name
ntu-93-D89724002-1.pdf
Size
23.31 KB
Format
Adobe PDF
Checksum
(MD5):50137f9d3bc605f108b51dc3cadfe654